Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
about
Coming of age: the artificial pancreas for type 1 diabetesGLP-1 Agonists in Type 1 Diabetes Mellitus.Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.Artificial Pancreas Project at Cambridge 2013Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes.Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?Adjunctive therapy for glucose control in patients with type 1 diabetes.
P2860
Q26745886-3C9BAB73-A015-414C-80C9-56EF9F5D2196Q34677451-619C936D-8BFF-4740-8CE5-6B9892A5038DQ35769584-A6410A83-06B2-4FB9-BBE6-C604A34E7A30Q35858586-3155A381-81CD-43B6-A7B8-8C3CDAA895E1Q37275418-727AB066-85F0-4155-8A74-900ED152EC24Q37652799-80CA966F-A698-48CD-98F5-BB3E16050A9AQ38580783-E546B056-8387-48B6-AE2D-52CEA3B40FA9Q38642435-FD93FEF5-A5AA-4C7E-AE6B-A2DC965F148FQ39140474-64C1A6C9-D710-4B27-803B-7C6F637B5B63Q39413453-054F4017-C993-4F2B-B2C7-8B74D7D1C62FQ51654262-4B584B37-CB20-453B-8890-3B3A0FA20A62Q52562630-E39E422D-CA3B-429B-A78E-5F971B6EE2AAQ55234623-ACBF8A39-520E-4091-A679-C0443F8EE788
P2860
Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@ast
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@en
type
label
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@ast
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@en
prefLabel
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@ast
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@en
P2093
P2860
P356
P1476
Role of glucagon-like peptide- ...... p setting with ePID algorithm.
@en
P2093
Jeniece Trast
Martin Cantwell
Neesha Ramchandani
Rubina A Heptulla
Venkat Sasidhar Renukuntla
P2860
P304
P356
10.1177/1932296814542153
P577
2014-07-16T00:00:00Z